A LIFE DEDICATED TO MEDICINE, RESEARCH AND IMPACT

Dr Samuel JK Abraham

Clinician Scientist | Researcher | Innovator

Dr Samuel JK Abraham is a clinician scientist with a passion for translational research and regenerative medicine. His work spans cardiac surgery, stem cell science, immunotherapy and innovative cell-based therapies, with a focus on translating research from bench to bedside for real-world impact.

BORN IN

Kurumbur, Tamil Nadu,
India

BASED IN

Yamanashi-ken,
Japan

PROFESSION

Clinician Scientist

SPECIALIZATION

Cardiac Surgery & Regenerative Medicine

INNOVATION FOR REAL-WORLD IMPACT

Key Contributions to Science & Society

Education, Positions & Professional Associations

Qualifications & Affiliations

01

Academic Foundations

Education and specialist medical training

Schooling

EARLY EDUCATION

SSLC — Tamil medium
HSC — English medium

Margoschis Higher Secondary School, Nazareth, Tamil Nadu, India

Primary Medical Degree

1992

Tirunelveli Medical College, India

Affiliated to Madurai Kamaraj University

Postgraduate Training

1994 — 1999

Cardiac Surgery, Yamanashi Medical University, Japan — completed 1999

PhD

1999

Yamanashi Medical University, Japan

02

Professional Journey

Academic appointments, fellowships and leadership

Lecturer

2012 — PRESENT

Centre for Advancing Clinical Research, Yamanashi University

Fellow — FRCP-L

Royal College of Physicians, London

Fellow — FIACTS

Indian Association of Cardiothoracic Surgeons

Head, R&D | Co-Founder & Director

2002 — PRESENT

GN Corporation Co. Ltd., Kofu, Japan

gncorporation.com ↗

Founder & Director

2005 — PRESENT

Nichi-In Centre for Regenerative Medicine (NCRM), India

ncrm.org ↗

Adjunct Faculty

APRIL 2012

INDICASAT, Panama

Visiting Professor

2010 — 2015

Tamil Nadu Dr. M.G.R. Medical University, India

Member, Scientific Board

International Stem Cell Academy

Co-Founder & Editorial Board Member

Journal of Stem Cells and Regenerative Medicine

Academic & professional journey: From medical education in Tamil Nadu to postgraduate training and continuing academic, research and professional work in Japan and internationally.

COLLABORATION FOR A HEALTHIER, MORE HUMAN FUTURE

Institutions & Affiliations

Research Interests

Exploring the translation of scientific concepts into practical applications across medicine, regenerative science, materials, biology and human health.

01 — TRANSLATIONAL RESEARCH • Translating bench-side technologies in in vitro cell culture and tissue engineering to bedside applications • Nanomaterials and polymers for regenerative medicine
02 — BIOMIMETIC SYSTEMS • Studying complex physico-chemical-biological interactions • Developing in vitro biomimicking systems using nanomaterials and controlled environments.
03 — HEALTHY AGING & SENESCENCE • Reversal of cellular senescence and exploration of healthy aging • In vitro and in vivo studies across varied physico-chemical-biological environments, including zero-gravity.
04 — IMMUNE SYSTEM & ADAPTABILITY • Development and evolution of the immune system • Poly-extremo tolerance and adaptability across the ladder of phylogeny.
05 — GUT MICROBIOME & IMMUNOMODULATION • Gut microbiome and immune balancing • Immunomodulation and the role of pre-biotics.
06 — GUT-BRAIN AXIS • Gut microbiome, immune systems and gut-brain interactions • Alpha-synuclein misfolding and its implications for neurodevelopmental and neurodegenerative diseases.

Projects Pursued

FROM CONCEPT TO REAL-WORLD APPLICATION

• Corneal limbal stem cells and endothelial progenitors.
• Hybrid Artificial Corneal Prosthesis.
• Hepatic progenitors for drug toxicology screening.
• Natural killer cell-based immunotherapy for cancer and viral infections.
• Human monoclonal antibodies for cancer.
• Cell-based therapies for anti-aging.
• In vitro expansion of human hematopoietic stem cells.
• NTissue engineering of human chondrocytes.
• Nanomaterial-based scaffolds for cell culture and tissue engineering.
•Dental stem cells and their applications in regenerative medicine.
• Autologous buccal mucosal cell-based therapies for male urethral stricture.
•Novel yeast strain-produced polysaccharides for human health and aging.

Medicine. Research. Ideas. Impact.

A continuing journey across disciplines, cultures and possibilities — connecting scientific research with clinical practice, innovation and society.

service 01

website designing

Sed quia magni sm doles eos qui ration volupta tem sequi.

service 02

website development

Sed quia magni sm doles eos qui ration volupta tem sequi.

service 03

mobile application

Sed quia magni sm doles eos qui ration volupta tem sequi.